Latham & Watkins Reps Boston Scientific In $1.3B Deal
Boston Scientific Corp. will pay up to $1.3 billion to buy California-based Cameron Health Inc., strengthening its arrhythmia management portfolio with the addition of the only commercially available subcutaneous implantable cardioverter-defibrillator,...To view the full article, register now.
Already a subscriber? Click here to view full article